Berlin - Delayed Quote EUR

BioXcel Therapeutics Inc (BX2.BE)

Compare
0.3046
-0.0065
(-2.09%)
As of 8:00:48 AM GMT+1. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
73,702.0000
205,853.0000
239,439.0000
219,936.0000
Total Liabilities Net Minority Interest
130,210.0000
129,078.0000
17,772.0000
13,240.0000
Total Equity Gross Minority Interest
-56,508.0000
76,775.0000
221,667.0000
206,696.0000
Total Capitalization
44,090.0000
169,826.0000
221,667.0000
206,696.0000
Common Stock Equity
-56,508.0000
76,775.0000
221,667.0000
206,696.0000
Capital Lease Obligations
786.0000
786.0000
1,105.0000
1,398.0000
Net Tangible Assets
-56,508.0000
76,775.0000
221,667.0000
206,696.0000
Working Capital
44,876.0000
169,970.0000
220,145.0000
205,223.0000
Invested Capital
44,090.0000
169,826.0000
221,667.0000
206,696.0000
Tangible Book Value
-56,508.0000
76,775.0000
221,667.0000
206,696.0000
Total Debt
101,384.0000
93,837.0000
1,105.0000
1,398.0000
Net Debt
35,377.0000
--
--
--
Share Issued
29,929.9970
28,147.0000
27,980.3450
24,417.0000
Ordinary Shares Number
29,929.9970
28,147.0000
27,980.3450
24,417.0000
12/31/2020 - 3/12/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers